CHESHIRE, Conn., Jan. 25 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals , will conduct a conference call and web cast on Thursday, January 26th at 9:00 a.m., eastern, to review the Phase III TRIUMPH clinical trial. To participate in this conference call, dial 913-981-5584, confirmation code 1942581 shortly before 9:00 a.m., eastern. A replay of the call will be available for a limited period following the call, beginning at 12:00 p.m., eastern. The replay number is 719-457-0820, confirmation code 1942581. The web cast can be accessed at: http://www.alexionpharm.com.
Alexion will issue a press release at 6:30 a.m., eastern, on Thursday, January 26th, providing preliminary results from the TRIUMPH trial.
Contacts: Alexion Pharmaceuticals, Inc. Leonard Bell, M.D. Chief Executive Officer (203) 272-2596 Rx Communications Rhonda Chiger (Investors) (917) 322-2569 Patricia Garrison (Scientific Media) (917) 322-2567 Noonan/Russo Emily Poe (Business and Financial Media) (212) 845-4266
Alexion Pharmaceuticals
CONTACT: Leonard Bell, M.D. Chief Executive Officer, AlexionPharmaceuticals, Inc., +1-203-272-2596; or Rhonda Chiger (Investors),+1-917-322-2569, or Patricia Garrison (Scientific Media), +1-917-322-2567,both of Rx Communications; or Emily Poe (Business and Financial Media) ofNoonan Russo, +1-212-845-4266
Web site: http://www.alexionpharm.com/
